Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
Lorenz Balcar(Paracelsus Medical University), Thomas Reiberger(Harvard University), David Bauer(Austrian Academy of Sciences), Marta Tonon(University of Padua), Alessandra Brocca(University of Padua), Lukas Hartl(Medical University of Vienna), Valeria Calvino(University of Padua), Simone Incicco(University of Padua), Carmine Gambino(University of Padua), Georg Semmler(Paracelsus Medical University), Benedikt Hofer(Medical University of Vienna), Mathias Jachs(Medical University of Vienna), Michael Trauner(Medical University of Graz), Mattias Mandorfer(Medical University of Vienna), Antonio Accetta(University of Padua), Salvatore Piano(University of Padua)
Cited by 80
Related Papers
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites
|Journal of Hepatology|2015|864
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561